Tacoma, WA – According to filings with the U.S. Securities and Exchange Commission, Revalesio is raising $26,771,147.00 in new funding. Sources indicate as part of senior management President, Greg Archambeau played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Revalesio

Revalesio Corporation, located in Tacoma, WA, is partnering with leaders in biomedical research around the globe to harness the benefits of fluid modification via turbulent Taylor-Couette-Poiseuille (TCP) flow. Revalesio’s patented application of fluid cavitation within a TCP flow environment has resulted in ground breaking publications in the disciplines of physical chemistry as well as biomedical science. Revalesio is dedicated to commercializing its discoveries through a global drug discovery research and development program that holds significant promise in the area of neurological disorders.

To learn more about Revalesio, visit http://revalesio.com/

Contact:
Greg Archambeau, President
253-922-2600
garchambeau@revalesio.com
https://www.linkedin.com/in/greg-archambeau-4394a71a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved